Bulgária - búlgaro - Изпълнителна агенция по лекарствата

astrazeneca ab - Фелодипин - 5 mg prolonged - release tablets

Bulgária - búlgaro - Изпълнителна агенция по лекарствата

astrazeneca ab - Езомепразол - 40 mg powder for solution for injection/infusion

União Europeia - búlgaro - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - Карцином, недребноклетъчен белодроб - Антинеопластични средства - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

União Europeia - búlgaro - EMA (European Medicines Agency)

astrazeneca ab - метформина хидрохлорид, Саксаглиптин, dapagliflozin - Захарен диабет тип 2 - Лекарства, използвани при диабет - qtrilmet е показан при възрастни на възраст 18 и повече години с диабет тип 2, за подобряване на гликемичния контрол при метформином или без сульфонилмочевины (Су) и саксаглиптин или dapagliflozin не осигурява адекватен гликемичен контрол . когато вече лекувани с метформин и саксаглиптин и dapagliflozin.

Bulgária - búlgaro - БАБХ (Българска агенция по безопасност на храните)

interchemie werken "de adelaar" b.v. - metamizole sodium monohydrate - инжекционен разтвор - 500 mg/ml - говеда, кучета, свине, телета

União Europeia - búlgaro - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - Простатни неоплазми - Ендокринна терапия - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

União Europeia - búlgaro - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - Ваксини - active immunisation against h5 subtype of influenza a virus.

Bulgária - búlgaro - Изпълнителна агенция по лекарствата

astrazeneca uk ltd. - Бупивакаин - 5 mg/ml solution for injection

Bulgária - búlgaro - Изпълнителна агенция по лекарствата

astrazeneca uk ltd. - Бупивакаин - 5 mg/ml solution for injection

Bulgária - búlgaro - Изпълнителна агенция по лекарствата

astrazeneca uk ltd - propofol - 10 mg/ml emulsion for injection/infusion